Gaucher Disease (GD) Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: G972E4C8CB66EN
Market Monitor Global

Abstracts

Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.

This report contains market size and forecasts of Gaucher Disease (GD) Drugs in Global, including the following market information:

Global Gaucher Disease (GD) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gaucher Disease (GD) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enzyme Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gaucher Disease (GD) Drugs include Sanofi, Shire, Actelion Pharma, Pfizer (Protalix) and ISU ABXIS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gaucher Disease (GD) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gaucher Disease (GD) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gaucher Disease (GD) Drugs Market Segment Percentages, by Type, 2021 (%)

• Enzyme Replacement Therapy
• Substrate Reduction Therapy

Global Gaucher Disease (GD) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gaucher Disease (GD) Drugs Market Segment Percentages, by Application, 2021 (%)

• Non-neuronopathic Gaucher Disease
• Neuronopathic Gaucher Disease

Global Gaucher Disease (GD) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gaucher Disease (GD) Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gaucher Disease (GD) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gaucher Disease (GD) Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Shire
• Actelion Pharma
• Pfizer (Protalix)
• ISU ABXIS

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gaucher Disease (GD) Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gaucher Disease (GD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GAUCHER DISEASE (GD) DRUGS OVERALL MARKET SIZE

2.1 Global Gaucher Disease (GD) Drugs Market Size: 2021 VS 2028
2.2 Global Gaucher Disease (GD) Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gaucher Disease (GD) Drugs Players in Global Market
3.2 Top Global Gaucher Disease (GD) Drugs Companies Ranked by Revenue
3.3 Global Gaucher Disease (GD) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Gaucher Disease (GD) Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gaucher Disease (GD) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Gaucher Disease (GD) Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gaucher Disease (GD) Drugs Market Size Markets, 2021 & 2028
  4.1.2 Enzyme Replacement Therapy
  4.1.3 Substrate Reduction Therapy
4.2 By Type - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
  4.2.1 By Type - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gaucher Disease (GD) Drugs Market Size, 2021 & 2028
  5.1.2 Non-neuronopathic Gaucher Disease
  5.1.3 Neuronopathic Gaucher Disease
5.2 By Application - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
  5.2.1 By Application - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gaucher Disease (GD) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
  6.2.1 By Region - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gaucher Disease (GD) Drugs Revenue, 2017-2028
  6.3.2 US Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.3.3 Canada Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.3.4 Mexico Gaucher Disease (GD) Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gaucher Disease (GD) Drugs Revenue, 2017-2028
  6.4.2 Germany Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.3 France Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.4 U.K. Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.5 Italy Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.6 Russia Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.4.8 Benelux Gaucher Disease (GD) Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gaucher Disease (GD) Drugs Revenue, 2017-2028
  6.5.2 China Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.5.3 Japan Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.5.4 South Korea Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.5.6 India Gaucher Disease (GD) Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gaucher Disease (GD) Drugs Revenue, 2017-2028
  6.6.2 Brazil Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.6.3 Argentina Gaucher Disease (GD) Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, 2017-2028
  6.7.2 Turkey Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.7.3 Israel Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Gaucher Disease (GD) Drugs Market Size, 2017-2028
  6.7.5 UAE Gaucher Disease (GD) Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Gaucher Disease (GD) Drugs Major Product Offerings
  7.1.4 Sanofi Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Shire
  7.2.1 Shire Corporate Summary
  7.2.2 Shire Business Overview
  7.2.3 Shire Gaucher Disease (GD) Drugs Major Product Offerings
  7.2.4 Shire Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
  7.2.5 Shire Key News
7.3 Actelion Pharma
  7.3.1 Actelion Pharma Corporate Summary
  7.3.2 Actelion Pharma Business Overview
  7.3.3 Actelion Pharma Gaucher Disease (GD) Drugs Major Product Offerings
  7.3.4 Actelion Pharma Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
  7.3.5 Actelion Pharma Key News
7.4 Pfizer (Protalix)
  7.4.1 Pfizer (Protalix) Corporate Summary
  7.4.2 Pfizer (Protalix) Business Overview
  7.4.3 Pfizer (Protalix) Gaucher Disease (GD) Drugs Major Product Offerings
  7.4.4 Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer (Protalix) Key News
7.5 ISU ABXIS
  7.5.1 ISU ABXIS Corporate Summary
  7.5.2 ISU ABXIS Business Overview
  7.5.3 ISU ABXIS Gaucher Disease (GD) Drugs Major Product Offerings
  7.5.4 ISU ABXIS Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
  7.5.5 ISU ABXIS Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gaucher Disease (GD) Drugs Market Opportunities & Trends in Global Market
Table 2. Gaucher Disease (GD) Drugs Market Drivers in Global Market
Table 3. Gaucher Disease (GD) Drugs Market Restraints in Global Market
Table 4. Key Players of Gaucher Disease (GD) Drugs in Global Market
Table 5. Top Gaucher Disease (GD) Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gaucher Disease (GD) Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gaucher Disease (GD) Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gaucher Disease (GD) Drugs Product Type
Table 9. List of Global Tier 1 Gaucher Disease (GD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gaucher Disease (GD) Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gaucher Disease (GD) Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Gaucher Disease (GD) Drugs Product Offerings
Table 32. Sanofi Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Shire Corporate Summary
Table 34. Shire Gaucher Disease (GD) Drugs Product Offerings
Table 35. Shire Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Actelion Pharma Corporate Summary
Table 37. Actelion Pharma Gaucher Disease (GD) Drugs Product Offerings
Table 38. Actelion Pharma Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer (Protalix) Corporate Summary
Table 40. Pfizer (Protalix) Gaucher Disease (GD) Drugs Product Offerings
Table 41. Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
Table 42. ISU ABXIS Corporate Summary
Table 43. ISU ABXIS Gaucher Disease (GD) Drugs Product Offerings
Table 44. ISU ABXIS Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gaucher Disease (GD) Drugs Segment by Type in 2021
Figure 2. Gaucher Disease (GD) Drugs Segment by Application in 2021
Figure 3. Global Gaucher Disease (GD) Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gaucher Disease (GD) Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gaucher Disease (GD) Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gaucher Disease (GD) Drugs Revenue in 2021
Figure 8. By Type - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 12. US Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 24. China Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Shire Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Actelion Pharma Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. ISU ABXIS Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)